trending Market Intelligence /marketintelligence/en/news-insights/trending/7n2m4nefohfwwkzjphjzha2 content esgSubNav
In This List

Dipexium Pharmaceuticals names chief medical officer

Blog

Insight Weekly: Layoffs swell; energy efficiency PE deals defy downturn; 2023 global risk themes

Blog

Insight Weekly: Energy crisis cripples Europe; i-bank incomes rise; US holiday sales outlook

Blog

Japan M&A By the Numbers: Q3 2022

Blog

Insight Weekly: Reviving nuclear power; 2023 outlook for US financials; PE funds fuel EV sector


Dipexium Pharmaceuticals names chief medical officer

New York-based drugmaker Dipexium Pharmaceuticals Inc. appointed Efthymios Deliargyris as chief medical officer.

Deliargyris was previously the chief medical adviser of the company.

Dipexium Pharmaceuticals is a late-stage pharmaceutical company, engaging in the development and marketing of antibiotics in the U.S.